PharmaSecure in talks to offer anti-counterfeit solutions

PharmaSecure PAS India is in talks with several leading pharma companies to offer its anti-counterfeit solutions of tracking and tracing medicines ahead of the government deadline of July 1.

In a bid to protect the 'Made in India' brand in the pharmaceutical space, PharmaSecure has received encouraging response from Indian drug companies for its anti-counterfeit solutions of tracking and tracing medicines ahead of the government deadline of July 1, 2011, PharmaSecure Director Kishore Kar told PTI here.

As per the notification issued by the Directorate General of Foreign Trade (DGFT), all exports of pharmaceutical products from India have to comply with these anti-counterfeit measures from the said date.

India, the third-largest drug production globally by volume and 14th by value, has increasingly witnessed spurious and counterfeit drugs made in China for African Countries, under the brand name of Indian drug companies. The $20-billion (Rs 90,000 crore) Indian pharmaceutical industry constitutes 40% exports.

Companies like Lupin, Unichem Laboratories and MSN Laboratories have already implemented PharmaSecure's solutions for some of their products, which enables the patient to ensure authenticity of the drug by sending an SMS.

PharmaSecure is offering complete Track and Trace solution to Indian manufacturers for their export products.

"This is the most effective tool to empower consumers; it is equivalent to creating an army of enforcement agents, who would participate in this drive against counterfeiting. Currently, we are rolling out this service for over 100 million packages in India," Kar said.